Trodelvy ASCENT trial results: 69/258 @ 26% SAE's
Post# of 151023
(Total Views: 232)
Posted On: 03/15/2025 9:00:27 PM
Trodelvy ASCENT trial results:
69/258 @ 26% SAE's.
13 of 69 = Febrile neutropenia.
Febrile neutropenia (FN) is a serious and potentially life-threatening complication of cancer treatment that occurs when a patient with neutropenia develops a fever. Neutropenia is a temporary reduction in white blood cells, specifically neutrophils, which help fight infections. FN is considered an oncologic emergency and patients should be evaluated by a doctor immediately. Symptoms include fever, shivers, shakes, and other signs of infection.
https://clinicaltrials.gov/study/NCT02574455?...ab=results
Gilead's Trodelvy is heading towards a VERY distant 2nd place.
A doctor refusing to look @ an approved Leronlimab, after a patient asks them to, could very well end up in legal.
Leronlimab is Life.
69/258 @ 26% SAE's.
13 of 69 = Febrile neutropenia.
Febrile neutropenia (FN) is a serious and potentially life-threatening complication of cancer treatment that occurs when a patient with neutropenia develops a fever. Neutropenia is a temporary reduction in white blood cells, specifically neutrophils, which help fight infections. FN is considered an oncologic emergency and patients should be evaluated by a doctor immediately. Symptoms include fever, shivers, shakes, and other signs of infection.
https://clinicaltrials.gov/study/NCT02574455?...ab=results
Gilead's Trodelvy is heading towards a VERY distant 2nd place.
A doctor refusing to look @ an approved Leronlimab, after a patient asks them to, could very well end up in legal.
Leronlimab is Life.
(2)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼